Trials / Unknown
UnknownNCT04175197
LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries
The LegDeb2 Global Registry for the Treatment of Superficial Femoral, Popliteal or Below-The-Knee Artery Lesions Using the Legflow DrugEluting Balloon
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 512 (estimated)
- Sponsor
- Federico II University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
LEGDEB2 is a Global Registry for the Treatment of Superficial Femoral and/or Popliteal or Below-The-Knee or Iliac Artery Lesions Using the Legflow Drug-Eluting Balloon
Detailed description
LEGDEB2 is a Global Registry aimed to prospectively collect and assess global safety and efficacy data on the Legflow Drug Eluting Balloon (DEB) in treatment of atherosclerotic disease of the superficial femoral and/or popliteal and/or below-the-knee and/or iliac arteries in "real world" patient population.
Conditions
- Peripheral Arterial Disease
- Superficial Femoral Artery Stenosis
- Iliac Artery Stenosis
- Arterial Occlusive Diseases
- Popliteal Artery Stenosis
- Critical Limb Ischemia
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Drug Coated Balloon | Legflow Drug Coated Balloon |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2019-11-22
- Last updated
- 2019-11-22
Locations
7 sites across 2 countries: Italy, Mexico
Source: ClinicalTrials.gov record NCT04175197. Inclusion in this directory is not an endorsement.